KARA FITZGERALD, ND completed a post-doctorate in nutritional biochemistry/laboratory science with Richard Lord, Ph.D. Author: Case Studies in Integrative and Functional Medicine, contributing author: Laboratory Evaluations for Integrative and Functional Medicine; IFM’s Textbook for Functional Medicine. She lectures globally on functional medicine; is on faculty at IFM and practices in Connecticut.

Veggies

Versatile One-Pan Veggies

Versatile One-Pan Veggies recipe is from Janine Henkel, MS, CNS, CN, one of our resident nutritionists. With today’s busy lifestyle, basic principles of a healthy diet can get easily lost to other priority tasks. Janine ensures that meals are based on simple, practical and delicious recipes, which motivates even the busiest professional, parent or those…

Clinician Position for SHC

Research and News January 2020

Unpicking Molecular Mechanisms Between Diet, Microbiome and Host – Focus on Ginger
Functional Medicine Needed to Help Solve Ever-Increasing BMIs
Novel Skin-Gut Axis Shows How Sunlight and Vitamin D Production May Modulate the Gut Microbiome
Vegan Diets – Popular But Are They Healthy?
Microbes in Natural Environments Play a Role in Immune Tolerance
Huge Increase in US Alcohol-Related Deaths
Tongue Fat and Other Causes of Macroglossia that Can Affect Sleep Apnea
Male Scientists’ Language Gets Them More Attention

Flaxseed Hair Gel

DIY Flaxseed Hair Gel

We are exposed to toxins every day – through our air, our water, our personal care and household products and much more. The good news is, there is a lot we can do to limit our exposure. As a functional nutritionist I believe choosing non-toxic, clean products is just as important as clean eating. That…

The Business of Functional Medicine: Secrets for Success for your own FxMed Practice

Episode 76: Sponsored | The Business of Functional Medicine: Secrets for Success for your own FxMed Practice

Dr. Jeff Gladd is a brilliant Fx/integrative physician who is PASSIONATE about all things Fx business. Learn about FS’s integrated EMR, our Clinic Immersion and Fx Residency programs, with top tips for building your brand. And so much more. Check out the show notes for loads of links, references, downloads and more, and be sure to leave a review wherever you listen to New Frontiers! As always, thank you for listening! ~DrKF

Plasmalogen Deficiency, Dementia, and Death with Dr. Dayan Goodenowe

Plasmalogen Deficiency, Dementia, and Death with Dr. Dayan Goodenowe

Dr. Goodenowe invented a technology platform in 1999 that has been used to analyze thousands of human samples from around the world. Through collaborations with international researchers and doctors, Dr. Goodenowe has become an expert on the biochemical basis of neurological diseases including Alzheimer’s, Parkinson’s, multiple sclerosis, autism, bipolar disorder, and schizophrenia. Prodrome Sciences uses Dr. Goodenowe’s technology and discoveries to develop blood tests and dietary supplements for the early detection and prevention of disease.

Episode 75: Aging as an Evolutionary Program with Dr. Josh Mitteldorf

Episode 75: Aging as an Evolutionary Program with Dr. Josh Mitteldorf

As FxMed docs, we’re committed to working with the body’s own capacity for health. Dr. Josh Mitteldorf offers a contrarian strategy, one which he says is grounded in a new breed of evolutionary medicine. He tells us that diseases of old age are qualitatively different from the diseases we get when we’re younger, different because in old age, our bodies are part of the problem, not part of the solution. Aging, says Josh, is the body deliberately destroying itself (for the sake of the population), via inflammation and apoptosis and autoimmune diseases. In this interview, Josh and I find common ground talking about hormesis. In Josh’s theory, the fact that the body lives longer when stressed (e.g. caloric restriction) is proof that the body isn’t trying its hardest to stay young when it’s not stressed.

Pathogenic Mechanisms of Lp(a)

The Lp(a) Conundrum

Lp(a): What do with DO with it? It’s an unequivocal CV risk marker, and its pathogenic mechanisms are multiple and far-reaching. Yet it’s notoriously refractory to treatment – pharma and FxMed. Get the low-down in this month’s blog: The Lp(a) Conundrum. As you will read in the blog opener, figuring out this conundrum is near and dear to my heart. Shout out to Ann Sims, RD, LD, CDE, CLS for support writing and providing references. Ann also suggested I podcast on NFFM with lipidologist Dr. Thomas Dayspring- we’re coordinating that as I type, so stay tuned. I’d love to hear from you on this one: how are you approaching Lp(a) in practice? Thank you! ~DrKF